Zafrens Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
15
Zafrens General Information
Description
Developer of life sciences products designed to generate insights at the interface of biology and engineering. The company's technology utilizes nanofabrication, messenger ribonucleic acid sequencing, multi-omics analysis, and longitudinal imaging, enabling the medical industry to map molecular states of single cells directly to their functional manifestations in drug discovery.
Contact Information
Website
www.zafrens.comCorporate Office
- 5890 Pacific Center Boulevard
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 5890 Pacific Center Boulevard
- Suite 200
- San Diego, CA 92121
- United States
Zafrens Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series A) | 03-Nov-2026 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Jan-2022 | $6M | $9M | Completed | Startup | |
| 1. Seed Round | $3M | $3M | Completed | Startup |
Zafrens Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-1 | 178,372 | $0.000100 | $0.9 | $0.9 | 1x | $0.9 | 0.41% | |
| Seed | 3,715,171 | $0.000100 | $1.61 | $1.61 | 1x | $1.61 | 8.61% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Zafrens Comparisons
Industry
Financing
Details
Zafrens Competitors (47)
One of Zafrens’s 47 competitors is ATUM (Biotechnology), a Formerly VC-backed company based in Newark, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ATUM (Biotechnology) | Formerly VC-backed | Newark, CA | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | ||||
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA | ||||
| Valo | Venture Capital-Backed | Lexington, MA |
Zafrens Patents
Zafrens Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026072889-A2 | Reversible transfer devices and uses thereof | Pending | 26-Sep-2024 | ||
| WO-2026072889-A3 | Reversible transfer devices and uses thereof | Pending | 26-Sep-2024 | ||
| WO-2025159784-A1 | Capture beads for use in assays | Pending | 23-Jan-2024 | ||
| WO-2025160235-A1 | Capture beads for use in assays | Pending | 23-Jan-2024 | ||
| US-20250236863-A1 | High throughput assays for identifying the biological response of a cell | Pending | 23-Jan-2024 | C12N15/1065 |
Zafrens Signals
Zafrens Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Global Brain | Venture Capital | Minority | ||
| imec.xpand | Venture Capital | Minority | ||
| KOFA Healthcare | Venture Capital | Minority | ||
| Mitsui Chemicals | Corporation | Minority | ||
| Prime Movers Lab | Venture Capital | Minority |
Zafrens FAQs
-
When was Zafrens founded?
Zafrens was founded in 2021.
-
Where is Zafrens headquartered?
Zafrens is headquartered in San Diego, CA.
-
What is the size of Zafrens?
Zafrens has 31 total employees.
-
What industry is Zafrens in?
Zafrens’s primary industry is Biotechnology.
-
Is Zafrens a private or public company?
Zafrens is a Private company.
-
What is Zafrens’s current revenue?
The current revenue for Zafrens is .
-
How much funding has Zafrens raised over time?
Zafrens has raised $38M.
-
Who are Zafrens’s investors?
Global Brain, imec.xpand, KOFA Healthcare, Mitsui Chemicals, and Prime Movers Lab are 5 of 15 investors who have invested in Zafrens.
-
Who are Zafrens’s competitors?
ATUM (Biotechnology), Deep Genomics, Integrated DNA Technologies, Twist Bioscience, and Valo are some of the 47 competitors of Zafrens.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process